soul trial oral semaglutide cardiovascular outcomes 2024 2025 Reduces CV Events in T2DM β (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine π§ͺ T2DM + ASCVD/CKD π Oral semaglutide 14 mg vs placebo π soul trial oral semaglutide cardiovascular
Description
Heres what has changed since the early hype.
This article examines clinical safety data, GI mechanisms, and how genetic predispositions may influence medication tolerance in IBD patients see
Low Appetite Meals
A provider review is required before any treatment recommendation is made
and Novo Nordisk A/S were sued Wednesday by a top compounding pharmacy that makes copycat versions of their blockbuster obesity and diabetes drugs.
Serving Egg Harbor Township and the Jersey Shore, Nutriamed offers GLP-1 weight loss programs with medical supervision, nutrition guidance, InBody tracking, and fitness support designed to protect strength and muscle mass.
